Clinical Trials Browser

INDUSTRY × Diabetes Mellitus, Insulin-Dependent, 12 × Capecitabine × Clear all

NCT03852251 2024-08-02

A Study of AK104, a PD-1/CTLA-4 Bispecific Antibody, for Advanced Solid Tumors or With mXELOX/XELOX as First-line Therapy for Advanced Gastric or GEJ Adenocarcinoma

Phase 1/2 Completed

Diabetes Mellitus, Insulin-Dependent, 12